10 Pharmaceutical Stocks to Buy Under $20 According to Jeremy Green’s Redmile Group
In this article, we discuss the 10 pharmaceutical stocks to buy under $20 according to Jeremy Green's Redmile Group portfolio based on Q3 holdings of the fund.
Pliant Therapeutics Inc. (PLRX)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Redmile Group Jeremy Green | 3,080,801 | $21,596 | -1% | 0.67% |
| 2. | Citadel Investment Group Ken Griffin | 1,377,508 | $9,657 | +4% | 0% |
| 3. | Point72 Asset Management Steve Cohen | 770,000 | $5,398 | -33% | 0.02% |
| 4. | Harvard Management Co Jane Mendillo | 562,379 | $3,942 | 0.39% | |
| 5. | Cormorant Asset Management Bihua Chen | 482,413 | $3,382 | 0.25% |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $30.23 | 22 | Officer | 137,080 | 2021-06-18 | Filing | |
| $29.43 | 3,728 | Officer | 137,102 | 2021-06-18 | Filing | |
| $28.62 | 8,750 | Officer | 140,830 | 2021-06-18 | Filing | |
| $33.69 | 243 | Officer, Director | 449,317 | 2021-06-14 | Filing | |
| $32.98 | 3,757 | Officer, Director | 449,560 | 2021-06-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 15,199 | $106,545 | 0% | |
| 2. | 5,839,160 | $40,933 | 11.1% | |
| 3. | 5,290 | $37,081 | 0.01% | |
| 4. | 5,075,325 | $35,578 | 0% | |
| 5. | 2,657,457 | $18,629 | 7.92% |
News See All
Is PLRX A Good Stock To Buy Now?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Billionaire Hedge Funds
